Ming‐Chi Lu

10.3k total citations · 1 hit paper
252 papers, 5.5k citations indexed

About

Ming‐Chi Lu is a scholar working on Rheumatology, Physiology and Molecular Biology. According to data from OpenAlex, Ming‐Chi Lu has authored 252 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Rheumatology, 57 papers in Physiology and 38 papers in Molecular Biology. Recurrent topics in Ming‐Chi Lu's work include Rheumatoid Arthritis Research and Therapies (47 papers), Systemic Lupus Erythematosus Research (42 papers) and Alzheimer's disease research and treatments (36 papers). Ming‐Chi Lu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (47 papers), Systemic Lupus Erythematosus Research (42 papers) and Alzheimer's disease research and treatments (36 papers). Ming‐Chi Lu collaborates with scholars based in Taiwan, United States and Canada. Ming‐Chi Lu's co-authors include Ning‐Sheng Lai, Mark A. Mintun, Michael J. Pontecorvo, Malcolm Koo, Abhinay D. Joshi, Hanoch Livneh, Daniel Skovronsky, Chia‐Li Yu, Chien‐Hsueh Tung and Hsien‐Bin Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Ming‐Chi Lu

232 papers receiving 5.4k citations

Hit Papers

Cerebral PET with florbetapir compared with neuropatholog... 2012 2026 2016 2021 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
    2012 572 citations Christopher M. Clark, Michael J. Pontecorvo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Chi Lu Taiwan 37 1.9k 1.6k 1.0k 1.0k 603 252 5.5k
Andrew Goodman United States 49 520 0.3× 830 0.5× 937 0.9× 1.3k 1.3× 287 0.5× 149 7.8k
Margery Gass United States 46 657 0.3× 951 0.6× 754 0.7× 1.1k 1.1× 951 1.6× 110 12.4k
Alireza Minagar United States 43 745 0.4× 403 0.3× 877 0.9× 1.8k 1.8× 483 0.8× 261 7.3k
Mohammad Ali Sahraian Iran 42 377 0.2× 637 0.4× 1.0k 1.0× 1.1k 1.1× 348 0.6× 447 7.5k
Ηλίας Ζιντζαράς Greece 48 1.6k 0.9× 310 0.2× 1.3k 1.3× 1.5k 1.5× 235 0.4× 213 8.3k
Chiara Benedetto Italy 49 915 0.5× 1.8k 1.2× 381 0.4× 1.3k 1.3× 141 0.2× 405 9.2k
Dennis Bourdette United States 56 606 0.3× 944 0.6× 845 0.8× 1.6k 1.6× 519 0.9× 251 9.2k
Kjell‐Morten Myhr Norway 49 425 0.2× 778 0.5× 761 0.7× 1.3k 1.3× 407 0.7× 211 7.6k
Howard Fillit United States 33 1.2k 0.6× 909 0.6× 308 0.3× 1.2k 1.1× 128 0.2× 85 5.6k
Erin M. Ramos United States 21 913 0.5× 1.2k 0.8× 135 0.1× 2.4k 2.4× 168 0.3× 39 6.2k

Countries citing papers authored by Ming‐Chi Lu

Since Specialization
Citations

This map shows the geographic impact of Ming‐Chi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Chi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Chi Lu more than expected).

Fields of papers citing papers by Ming‐Chi Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Chi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Chi Lu. The network helps show where Ming‐Chi Lu may publish in the future.

Co-authorship network of co-authors of Ming‐Chi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Chi Lu. A scholar is included among the top collaborators of Ming‐Chi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Chi Lu. Ming‐Chi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Ming‐Chi, Amanda Sheffield Morris, Rose Beck, et al.. (2025). Analytical Validation and Performance of a Blood-Based P-tau217 Diagnostic Test for Alzheimer Disease. The Journal of Applied Laboratory Medicine. 10(3). 533–545. 4 indexed citations
2.
Lu, Ming‐Chi, et al.. (2025). Predicting HbA1c Target Achievement in Type 2 Diabetes: A Retrospective Single-Centre Nomogram Derived From National MMC-Standardised Management. Diabetes Metabolic Syndrome and Obesity. Volume 18. 3589–3600. 1 indexed citations
3.
4.
Ma, Jun, Michael P. Randall, Ming‐Chi Lu, et al.. (2024). BTK Degradation As a Novel Therapeutic Strategy in Relapsed CNS Lymphoma: Proof of Concept Studies in Intracranial Patient-Derived, Rodent Models. Blood. 144(Supplement 1). 2988–2988. 1 indexed citations
5.
6.
Hodsdon, Michael E., Ming‐Chi Lu, Amanda Sheffield Morris, et al.. (2024). Clinical validation of the Eli Lilly SPX P‐tau217 blood‐based immunoassay as a laboratory‐developed test (LDT). Alzheimer s & Dementia. 20(S8).
7.
8.
Koo, Malcolm & Ming‐Chi Lu. (2023). Performance of a New Instrument for the Measurement of Systemic Lupus Erythematosus Disease Activity: The SLE-DAS. Medicina. 59(12). 2097–2097. 2 indexed citations
9.
Shcherbinin, Sergey, Ivelina Gueorguieva, Cynthia Evans, et al.. (2023). Amyloid re‐accumulation after donanemab treatment: summary from 3 interventional trials. Alzheimer s & Dementia. 19(S14). 3 indexed citations
10.
Hsu, Chia‐Wen, et al.. (2022). Factors associated with intimacy in female Taiwanese patients with systemic lupus erythematosus: a cross-sectional study. BMJ Open. 12(4). e055754–e055754. 2 indexed citations
11.
Lai, Ning‐Sheng, Ming‐Chi Lu, Chia‐Wen Hsu, et al.. (2021). Association of Traditional Chinese Medicine Body Constitution and Health-Related Quality of Life in Female Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study. Evidence-based Complementary and Alternative Medicine. 2021. 1–11. 6 indexed citations
12.
Livneh, Hanoch, et al.. (2019). Decreased Risk of Dementia Among Patients With Traumatic Brain Injury Receiving Acupuncture Treatment: A Population-Based Retrospective Cohort Study. Journal of Head Trauma Rehabilitation. 34(5). E17–E23. 10 indexed citations
13.
Lu, Ming‐Chi, et al.. (2019). Factors associated with disease-specific quality of life in Taiwanese patients with ankylosing spondylitis: a cross-sectional study. BMJ Open. 9(6). e028966–e028966. 6 indexed citations
14.
15.
16.
Johnson, Keith A., Reisa A. Sperling, Christopher Gidicsin, et al.. (2013). Florbetapir (F18‐AV‐45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging. Alzheimer s & Dementia. 9(5S). S72–83. 190 indexed citations
17.
Yu, Hui-Chun, Ming‐Chi Lu, Chin Li, et al.. (2013). Targeted Delivery of an Antigenic Peptide to the Endoplasmic Reticulum: Application for Development of a Peptide Therapy for Ankylosing Spondylitis. PLoS ONE. 8(10). e77451–e77451. 11 indexed citations
18.
Huang, Kuang‐Yung, et al.. (2007). Treatment of DMARD-Resistant Active Rheumatoid Arthritis Patients with Leflunomide: Central Taiwan Experience. 21(1). 57–63. 1 indexed citations
19.
Lu, Ming‐Chi, Ko‐Jen Li, Song‐Chou Hsieh, Chih-Hao Wu, & Chia‐Li Yu. (2006). Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus.. PubMed. 39(6). 471–5. 10 indexed citations
20.
Lu, Ming‐Chi, et al.. (2001). [Clinical significance of the expression of lung resistance protein in non-small cell lung carcinomas].. PubMed. 24(8). 458–60. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Goodman Breakdown of academic impact, for papers by Margery Gass Breakdown of academic impact, for papers by Alireza Minagar Breakdown of academic impact, for papers by Mohammad Ali Sahraian Breakdown of academic impact, for papers by Ηλίας Ζιντζαράς Breakdown of academic impact, for papers by Chiara Benedetto Breakdown of academic impact, for papers by Dennis Bourdette Breakdown of academic impact, for papers by Kjell‐Morten Myhr Breakdown of academic impact, for papers by Howard Fillit Breakdown of academic impact, for papers by Erin M. Ramos
Rankless by CCL
2026